Le Lézard
Classified in: Health
Subject: SVY

Medical Device Regulation Seminar: Eurasion Union, Russia and the CIS (London, United Kingdom - October 9-10, 2018)


DUBLIN, July 19, 2018 /PRNewswire/ --

The "Medical Device Regulation in the Eurasion Union, Russia and the CIS" conference has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

A comprehensive overview of medical device regulatory affairs in Russia and the Eurasian Union. Key countries covered include Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russia, Tajikistan, Turkmenistan and Ukraine.

The aim of this seminar is to provide a comprehensive overview of medical device regulatory affairs in Russia and the Eurasian Union. This interactive meeting will discuss the regulatory requirements within these regions. The focus will be on practical aspects to assist in developing your regulatory strategy for product approval in these countries. The presentations will also give practical hints on the regulatory and registration process where possible.

Attending this programme will:

Who Should Attend:

This seminar will be of particular interest to:

Agenda:

Day one - Russia

Russia - the competitive landscape

National standards

Registration of medical devices in Russia

Day two - CIS and EAEU

CIS - Regional regulatory overview

Eurasian regulations for medical devices

Registration of medical devices in CIS

Practical workshop

For more information about this conference visit https://www.researchandmarkets.com/research/wsgj4d/medical_device?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...

at 02:00
In response to the increasing complexities of the aging journey and the rising trend of...

at 02:00
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...



News published on and distributed by: